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Small molecule inhibitors are prime reagents for studies in microtubule cytoskeleton
research, being applicable across a range of biological models and not requiring genetic
engineering. However, traditional chemical inhibitors cannot be experimentally applied with
spatiotemporal precision suiting the length and time scales inherent to microtubule-
dependent cellular processes. We have synthesised photoswitchable paclitaxel-based
microtubule stabilisers, whose binding is induced by photoisomerisation to their meta-
stable state. Photoisomerising these reagents in living cells allows optical control over
microtubule network integrity and dynamics, cell division and survival, with biological
response on the timescale of seconds and spatial precision to the level of individual cells
within a population. In primary neurons, they enable regulation of microtubule dynamics
resolved to subcellular regions within individual neurites. These azobenzene-based micro-
tubule stabilisers thus enable non-invasive, spatiotemporally precise modulation of the
microtubule cytoskeleton in living cells, and promise new possibilities for studying intracel-
lular transport, cell motility, and neuronal physiology.
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The cytoskeleton serves as the scaffold for critical biologicalprocesses ranging from signalling and cargo trafficking, tocell shape maintenance and cell division. Most of the
cytoskeleton’s myriad of biological roles are inherently spatially
and temporally differentiated, although they all rely on the same
protein scaffold structures. Studying these cytoskeleton-
dependent processes with the spatiotemporal resolution neces-
sary to understand and exploit these individual biological func-
tions is an important challenge. Accordingly, in recent years, a
number of approaches towards photocontrol over cytoskeletal or
cytoskeleton-associated proteins have been made, aiming to allow
their spatiotemporally precise optical manipulation1–3. Never-
theless, much remains to be done before generally applicable tool
systems can be developed.
We here focus on the microtubule (MT) cytoskeleton. MTs
play particularly important roles in intracellular transport, cell
motility and morphological plasticity, and there is a conspicuous
need to achieve a better understanding of how these many
functions are implemented and regulated4,5. The role of MT
dynamics during cell proliferation has also made them a major
anticancer target, for which several outstanding drugs (taxanes,
epothilones and vinca alkaloids) have been developed6–8. These
drugs and other small molecule modulators (e.g., nocodazole,
combretastatin and peloruside) remain the most general tools for
MT cytoskeleton research. However, these inhibitors simulta-
neously suppress all MT-dependent functions spatially indis-
criminately. Therefore, they do not allow spatiotemporally precise
MT inhibition on the length or time scales appropriate for
selectively studying MT-dependent processes. This restricts their
scope of applications and their utility for selective research into
MT cytoskeleton biology9.
Deeper insights could be gained from inhibitors that allow
spatiotemporally specific MT manipulation. In this regard,
optogenetic approaches to MT regulation have advanced greatly
in recent years. In one example, a photo-inactivatable variant of
the MT plus tip adaptor protein EB1 was engineered, which upon
illumination lost its ability to bind other plus-end-tracking pro-
teins, thus optically inhibiting MT growth and allowing spatio-
temporally resolved modulation of directional cell migration10.
Another domain of research has focused on optogenetic switches
tethered to kinesins and compartment identity markers, to
manipulate the transport of vesicles and organelles. With such
methods, it is possible to photomodulate the association of motor
proteins to cargos, to investigate the role of MTs in specific
transport processes11,12.
However, while optogenetics has succeeded in providing
motors and scaffold-associated proteins that are responsive to
externally controlled stimuli, no optogenetic variants of the basic
cytoskeleton scaffold proteins actin and tubulin have been
achieved. An exogenously controllable system for directly pat-
terning cytoskeleton scaffold dynamics and structure with spa-
tiotemporal resolution would however be highly desirable, since it
would allow researchers to modulate any of the cytoskeleton-
dependent functions. For this purpose, pharmacological inter-
ventions that directly address the stability and dynamics of the
cytoskeleton scaffold remain the methods of choice. For example,
photouncageable versions of MT inhibitors, particularly of the
blockbuster drug paclitaxel, have been used for localised photo-
activatable inhibition of MT dynamics in several studies13,14. Yet
despite their ability to modulate the cytoskeleton directly, pho-
touncaging approaches suffer disadvantages, such as irreversi-
bility of inhibition, the intense and phototoxic mid-UV
illumination typically needed for uncaging, the often slow and
rate-limiting intermediate hydrolysis that diminishes their pre-
cision of temporal control, their release of nonspecifically toxic
and also phototoxic photouncaging byproducts, background
activity through enzymatic hydrolysis, and increased molecular
weight that can cause biodistribution problems15.
Against this background, photopharmaceuticals—photo-
switchably potent exogenous small molecule inhibitors—have
been extensively developed in recent years16–19. Photo-
pharmaceuticals conceptually enable studies not otherwise
accessible to biology, marrying the spatiotemporal precision of
light application known from optogenetics, to the flexibility and
system-independence of exogenous small molecule inhibitors.
This combination is favourable for non-invasive studies of tem-
porally regulated, spatially anisotropic biological systems—such
as the MT cytoskeleton16,19,20. Photopharmaceuticals have suc-
ceeded in delivering a measure of optical control over a broad
range of biochemical and biological phenomena, with early cell-
free studies now supplanted by applications in cultured cells and
recently in vivo in embryonic and adult animals21–24.
In the cytoskeleton field, several photopharmaceutical MT
destabilisers were recently developed, to begin addressing the
need for spatiotemporally precise MT cytoskeleton studies. The
azobenzene-based Photostatins (PSTs), which can be reversibly
photoswitched by low-intensity visible light between their biolo-
gically inactive E-isomers and their MT-destabilising colchicine-
like Z-isomers, were first developed in 201416,25–27. MT-
destabilising photopharmaceuticals based on two different
families of molecular photoswitch—styrylbenzothiazoles
(SBTubs)28 and hemithioindigos (bi-active HOTubs29 and dark-
active HITubs30)—have since been developed, delivering
increased metabolic robustness in the intracellular environment
and alternative optical switching profiles (all-visible switching
with hemithioindigos, GFP-orthogonal switching with SBTubs).
All three reagent families have enabled spatiotemporally precise
optical control over endogenous MT network integrity, MT
polymerisation dynamics, cell division and cell death. PSTs have
already been used in animals to tackle unsolved questions in
mammalian development21,22 and neuroscience31. These appli-
cations illustrate the power of photopharmacology to enable
previously inaccessible studies of spatiotemporally anisotropic
cytoskeletal processes without genetic engineering.
With the optically precise destabilisation of MTs addressed by
a range of agents, we desired to develop photopharmaceutical MT
stabilisers as conceptually novel tools with an alternative spec-
trum of biological research applications. While both MT desta-
bilisers and MT stabilisers can be used to suppress MT
polymerisation dynamics in cell culture, stabilisers have enabled a
variety of research and human therapeutic applications which are
inaccessible to destabilisers14,32,33, due to their differing phar-
macology, stoichiometry and spectrum of biological effects. Since
the biological functions of the MT cytoskeleton are primarily
dependent on the localisation of stabilised or growing MTs
themselves, we reasoned that optically controlled tools modulat-
ing MT network stability could allow spatiotemporally precise
stimulation of a range of these MT-dependent functions, in ways
not otherwise amenable to control.
We therefore chose to develop light-responsive paclitaxel
analogues as optically controlled MT stabilisers for in situ spa-
tiotemporally precise photocontrol of cellular MT network
architecture, dynamics and MT-dependent functions. We now
report our development of these reagents.
Results
Design and synthesis. We chose the azobenzene photoswitch for
installing photoswitchable potency onto the taxane core. This
photoswitch offers a substantial geometric change upon iso-
merisation, which we hoped would differentiate the isomers’
binding constants, and it allows reliable, high-quantum-yield,
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18389-6
2 NATURE COMMUNICATIONS |         (2020) 11:4640 | https://doi.org/10.1038/s41467-020-18389-6 | www.nature.com/naturecommunications
near-UV/visible-light-mediated, highly robust E↔Z photo-
isomerisability, which enables repeated photoswitching in situ in
living cells. Taxanes feature a number of chemically modifiable
positions; we chose to focus on sites where substituents can be
tolerated, but where their geometric changes might impact
binding potency through steric interactions or by modulating the
orientation of key interacting groups nearby. Potent taxanes
feature a side-chain 3′-amine acylatedsubstituted with mid-size
hydrophobic groups (e.g., Boc group in docetaxel and Bz in
paclitaxel)8,34 which abut the tubulin protein surface yet are
projected away from the protein interior (Fig. 1a, highlighted in
pink); the other side-chain positions (e.g., the 3′-phenyl or 2′-
hydroxyl) offer less tolerance for substitution as they project into
the protein8. The 3′-amine also tolerates the attachment of
somewhat polar cargos such as the large silarhodamine fluor-
ophore, as long as they are attached via a long spacer, with only
moderate potency loss35, making it desirable for photo-
pharmaceutical tuning as it might tolerate azobenzenes with a
range of structural characteristics. However, we anticipated that
attenuating the high potency of paclitaxel itself (low nM range)
might be required, in order that the relatively small structural
change of a E/Z isomerisation at the molecular periphery could
substantially modify the overall potency.
We accordingly designed a panel of 3′-azobenzamide-taxanes
(AzTax) for biological testing. As taxanes have famously poor
aqueous solubility (still worsened by attaching an azobenzene),
we initially determined to focus on compounds displaying
satisfactory potency at concentrations substantially below their
solubility limit. This avoids the case that the compounds’
apparent potencies would be dictated by solubility effects, and
so should enable robust use as reagents across a variety of systems
and settings. Theorising that the sterics around the azobenzene
phenyl ring proximal to the taxane core would be the greatest
potency-affecting factor, we first focussed on testing which
orientations of photoswitch would be best tolerated. We therefore
scanned orientations of the diazene in ortho, meta and para
relative to the amide (AzTax2/3/4 compound sets, Fig. 1b, c), and
when early cellular testing showed that the AzTax2 set had the
lowest potency, we abandoned it at this stage.
Next, examination of the published tubulin:paclitaxel cryo-EM
structures (Fig. 1a)36,37 indicated that the azobenzene’s distal ring
can project freely away from the protein. Therefore, we
hypothesised that steric variation to the distal ring would not
greatly impact binding potency of either isomer, but could be
used orthogonally to tune their photochemical properties, by
substitutions in para to the diazene that chiefly mesomerically
affect the photochemistry of the N=N double bond. We
accordingly synthesised unsubstituted (“H”), para-methoxy
(“MP”) and para-dimethylamino (“DMA”) derivatives of the
AzTax3/4 sets. These were chosen to vary the photochemical
properties of most relevance to photopharmacology: the com-
pleteness of the E→Z and the Z→E photoisomerisations at fixed
wavelengths, which dictate the dynamic range of isomer
photoswitchability, and τ (the halflife of the spontaneous
unidirectional Z→E relaxation). Lastly, when the AzTax3 set
proved promising in early studies, we also examined installing an
electron-donating 3,4,5-trimethoxy motif on the distal ring
(AzTax3TM) as well as an additional R3 methoxy group to
reduce the rotatability of the proximal ring in case this could
amplify the difference between isomer potencies (AzTax3MTM),
and we controlled for solubility effects by exchanging the
dimethylamino substituent for a more soluble diethanolamino
(“DEA”) group (AzTax3DEA). The target AzTax were synthe-
sised by degradation of commercial docetaxel followed by amide
couplings to various azobenzenecarboxylic acids in moderate
yields (Fig. 1b, c and Supplementary Note 1).
Photochemical characterisation. The AzTax all displayed robust
and repeatable E↔Z photoswitching under near-UV/visible
illuminations, as expected from the literature19 (Supplementary
Fig. 1). Since their protein target is located in the cytosol, we first
wished to evaluate their photoswitching in physiological aqueous
media. Since taxanes are too poorly water-soluble to perform
reliable photoswitching studies easily by UV–Vis spectroscopy,
we synthesised fully water-soluble diethanolamides of all the
azobenzenecarboxylic acids and used them in aqueous photo-
switching tests (see Supplementary Note 2). The photochemical
properties within each substituent set were similar. The unsub-
stituted (H) compounds displayed a 3-fold dynamic range of Z-
isomer photoswitchability between the photostationary states







Fig. 1 Design and synthesis of AzTax. a Paclitaxel:tubulin structure (PDB:
3J6G36) with the benzamide indicated in pink. b Synthesis of AzTax from
docetaxel. c Panel of AzTax examined in this study.
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substantially slower relaxation than biological timescales (τ ca.
50 days). The methoxylated compounds (MP, TM and MTM)
had been chosen to improve the dynamic range of isomer pho-
toswitching by relative shifting of the isomers’ absorption bands16
(Supplementary Fig. 2). Indeed, they delivered a ca. 9-fold
dynamic range of Z-isomer photoswitchability (375 nm: 96% Z;
530 nm: 11% Z), and their relaxation remained substantially
slower than biological timescales (τ ca. 24 h).
Advantageously for practical work, the metastable Z-isomers of
all AzTaxs could be quantitatively relaxed to E by warming
DMSO stocks to 60 °C overnight (which increases the practical
ease-of-use of these reagents as compared to irreversibly
photouncaged reagents). The para-amino (DMA and DEA)
compounds featured τ values too small to observe bulk
photoswitching in aqueous media under biologically applicable
conditions. Yet, since less water-solvated environments such as
lipid vesicles, membranes, or protein-adsorbed states are likely
intracellular localisations for hydrophobic taxane conjugates, we
then determined their photochemistry in moderately polar
aprotic media (EtOAc). Here, they were easily bulk-switchable
(τ ca. 11 min), giving a 4-fold dynamic range of Z-isomer
photoswitchability (410 nm: 91% Z; 530 nm: 21% Z) (further
detail in Supplementary Note 2). As the AzTax reagents were
intended for use with microscopy, we also examined photo-
switching of all compounds over a broader range of wavelengths,
to determine what dynamic range of isomer photoswitchability
would be accessible in practice, with standard (405, 488 and 514
nm) or more exotic (380, 440 and 532 nm) microscopy laser
wavelengths (Fig. 2a, Supplementary Fig. 2 and Supplementary
Table 1).
We then proceeded to explore the biological applicability of
AzTax as photoswitchable MT stabilisers in living cells. Since
near-UV illumination gave PSSs with high-Z populations for all
photoswitches, while thermal relaxation and maintenance in the
dark returned the E-isomer quantitatively, we began by compar-
ing all-E “dark” conditions (all-E stock applied, then maintained
dark) with mostly Z “360 nm” lit conditions (all-E stock applied,
then photoisomerised in situ by pulsed illuminations with low-
power 360 nm LED light, giving a mostly-Z PSS), to determine
which structures allowed the highest fold difference of bioactivity.
AzTax display photocontrolled bioactivity in living cells. Since
stabilisation of MTs in cells over a prolonged period blocks cell
proliferation and ultimately causes cell death8, we first assayed the
AzTax for light-dependent cellular activity by the resazurin cell
proliferation/viability assay. Viability dose-response curves under
dark or UV conditions were assessed in the HeLa cervical cancer
cell line (Fig. 2b, c). All compounds displayed dose-response
curves with similar Hill coefficients as the parent drug docetaxel
(Supplementary Fig. 3), which is in line with the conjecture that
they act through the same mechanism, albeit with different
potency. All compounds except the fast-relaxing AzTax3DMA
had Z-isomers that were more potent, or else equipotent, to the E-
isomers, suggesting that this trend in isomer-dependent cellular
bioactivity across several photoswitch types has robust sig-
nificance. E-AzTax2MP had the poorest overall potency (EC50 ca.
7 µM, all-E), which we took as indicating the unsuitability of
ortho substitutions that likely project the azobenzene into solu-
tion (c.f. Fig. 1a) where its hydrophobicity could interfere with
binding stability. By contrast, the AzTax4 set featured com-
pounds up to 100 times more potent, and structure-dependently
covered a 40-fold potency range. However, despite the good
isomeric photoswitchability of e.g., AzTax4MP, none of the
AzTax4 set displayed substantial photoswitchability of bioactivity
(fold difference between the 360 nm and the dark bioactivity). We
interpreted this substitution-independent result as an indication
that the distal ring may project too far from the protein contact
surface, in both E- and Z-isomers, for the AzTax4 isomer state to
substantially affect binding.
In contrast, members of the AzTax3 series all showed
photoswitchability of bioactivity. AzTax3MP featured a nearly
6-fold difference between the more-toxic Z and less-toxic E-
isomers’ bioactivity, over the 48 h experimental time course
(Fig. 2b). Adding more methoxy groups to the scaffold decreased
the Z-isomer’s cytotoxicity without greatly affecting that of the E-
isomer (AzTax3TM, AzTax3MTM), and deleting the methoxy
group also decreased the Z-isomer’s cytotoxicity (AzTax3H),
which we took as a sign that balancing the polarity of the
photoswitch was important for maximising bioactivity. In line
with this interpretation, the potencies of AzTax3DMA were
similar to AzTax4DMA while the more hydrophilic AzTax3DEA
showed a 40-fold loss of potency. Despite the potential for
photoswitching the para-amino AzTax inside lipid environments,
they should only reach their cytosolic target tubulin as the E-
isomers due to fast aqueous relaxation. Surprisingly,
AzTax3DMA appeared slightly more bioactive as the unillumi-
nated E-isomer, although as expected AzTax4DMA and
AzTax3DEA both showed no illumination-dependency of
bioactivity; and controls under 410 nm illumination (to establish
the optimum PSS for the para-amino compounds) showed no
different result to those obtained with UV illumination (Fig. 2).
The apparent cytotoxicity differential seen for AzTax3DMA
might reflect reduced availability to the cytosol rather than
a b
c d
Fig. 2 Photoswitchable performance of AzTax. a Photostationary state
UV–Vis absorption spectra of AzTax3MP under a range of cell-compatible
wavelengths similar to microscopy laser lines. b, c Resazurin
antiproliferation assays of AzTax highlight their structure- and light-
dependent cell cytotoxicity. HeLa cells, 40 h incubation in dark conditions
(all-E) or under pulsed illuminations with low-power LEDs (75ms per 15 s
near-UV at < 1 mWcm-2; lit = ~80% Z) (dose-response curves are fitted to
the means (shown with s.d.) of 3 independent biological experiments). d A
cell-free assay for polymerisation of purified tubulin comparing the MT
stabilisation activity of docetaxel, all-E- and 360 nm-lit-AzTax3MP (all 10
µM) shows light-specific promotion of polymerisation by Z-AzTax3MP,
matching the trend observed in cellular assays.
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differential binding of the isomers30 although these results do not
allow further conjecture.
To continue the study, we therefore selected AzTax3MP, due
to its photoswitchability of bioactivity (6-fold when under
optimum illumination conditions), satisfactory potency (EC50=
0.24 µM when UV illuminated), bidirectional photoswitchability
(optimum 9-fold-change of concentration of the more bioactive
Z-isomer), and reproducibly photoswitchable cellular perfor-
mance across assays with different illumination conditions, to
proceed with further mechanistic biological evaluations.
Photocontrol of tubulin polymerisation and cell cycle. To
examine the molecular mechanism of AzTax isomer-dependent
cellular bioactivity, we first assayed the potency of AzTax3MP for
promoting tubulin polymerisation in cell-free assays using pur-
ified tubulin. The majority-Z 360 nm-lit state gave a ca. 60%
enhancement of polymerisation over control (benchmarked to
docetaxel at 100%), while all-E-AzTax3MP gave only ca. 30%
polymerisation enhancement (Fig. 2d and Supplementary
Note 2). Note that the enhancements seen in this cell-free assay
are not predictive of the relative cellular potencies, but it clarifies
the mechanism of action of AzTax as MT stabilisers, like their
parent taxanes. We next studied the direct effects of in situ-
photoisomerised AzTax upon cellular MT organisation and MT-
dependent processes. Immunofluorescence imaging of cells after
24 h of exposure revealed that AzTax3MP light-dependently
disrupts MT network architecture. As AzTax concentration
increases, MTs first become disorganised, then mitotic spindle
defects that result in multinucleated cells are seen, and finally
mitotically arrested and early apoptotic cells with fragmented
nuclei dominate; the effective concentrations needed to achieve
these effects are substantially lower for lit AzTax than under all-E
dark conditions (Fig. 3, further detail in Supplementary Note 4).
The best window for visualising this isomer-dependent bioactivity
lay around 0.3–1 µM. Both the mitotic arrest, and the nuclear
defects of cells that escape arrest, are hallmarks of MT stabiliser
treatment38, arguing that the isomer-dependent cytotoxicity of
AzTax3MP arises from MT stabilisation preferentially by its Z-
isomer.
The presence of multinucleated cells indicated that AzTax also
inhibit MT-dependent functions such as successful completion of
mitosis. To quantify this we examined cell-cycle repartition after
AzTax treatment by flow cytometry, expecting to observe G2/M-
phase cell-cycle arrest39. G2/M-arrest was observed with approx-
imate EC50 around 1.5 µM after 24 h incubation with the lit
AzTax3MP. This was twice as potent as E-AzTax (Fig. 4a–c) and
mimicked the effect of docetaxel although with lower potency
(Supplementary Fig. 4). As a control for illumination/photo-
switch-dependent off-target effects, we also examined the non-
photoswitchably bioactive but potent AzTax4DMA, which
reproduced the effects of docetaxel independent of illumination
conditions indicating no significant assay complications (Supple-
mentary Fig. 4). This further supported the notion that
AzTax3MP acts across a range of assays and readouts as a
light-modulated taxane, with reproducible photocontrol over the
isomers’ bioactivity, allowing effective inhibition both of MTs and
of MT-dependent processes.
AzTax enable spatiotemporally specific MT control in cells.
With their photoisomerisation-dependent bioactivity shown in
long-term experiments (days), we next tested one of the key
conceptual advantages that photoswitchable MT stabilisers
should enable: real-time in situ optical control of the MT cytos-
keleton with single-cell spatial specificity and high temporal
precision.
We transfected HeLa cells to express the EB3-tdTomato
fluorescent reporter, that selectively labels GTP:tubulin-rich
regions of MTs. In ordinary conditions this is a marker for the
GTP cap region of polymerising MTs, thus selectively revealing
polymerising MTs as comets moving towards the cell periphery40.
As taxane treatment suppresses MT polymerisation dynamics41,
we imaged EB3-tdTomato dynamics using live cell confocal
microscopy, as a spatiotemporally resolved readout for MT
inhibition by AzTax.
We applied AzTax3MP globally to these cells at 1 µM, and
targeted single cells with low-intensity illuminations at 405 nm,
hoping to achieve precisely temporally resolved control of MT
dynamics in those single cells only, by selectively isomerising
AzTax3MP inside them. In targeted cells, EB3 comet counts were
halved upon 405 nm illuminations, recovering almost completely
within 80 s after 405 nm illumination was stopped (Fig. 5a), while
surrounding cells as well as non-treated controls were unaffected
(Fig. 5b); and the process could be repeated over several cycles
(Supplementary Movies 1 and 2, Supplementary Note 4 and
Supplementary Discussion). Thus, AzTax can indeed be used to
reversibly inhibit MT dynamics of target cells with temporal
precision on the scale of seconds and spatial precision on the level
of tens of microns. To examine E-AzTax3MP (dark state) for
residual effects on MT dynamics, we also quantified other
parameters of EB3 motility. E-AzTax3MP caused only a slight
decrease in EB3 comet velocities (Fig. 5c), and an insignificant
decrease in EB3 comet density (Fig. 5d). By comparison, in
photoswitched cells, so few comets remain that meaningful
velocity quantification was not possible (Fig. 5c, d). It can be
concluded that working concentrations can be appropriately
chosen such that AzTax3MP does not hinder MT polymerisation
in the absence of illumination, but does so strongly when
illuminated.
Finally, to study the entire cellular MT population and not only
the actively polymerising fraction of MTs, HeLa cells transfected
to express mCherry-α-tubulin were imaged to quantify total MT
density under AzTax3MP treatment (Supplementary Movies 3
and 4). No change in MT density was observed during treatment
or photoswitching (Supplementary Fig. 5). Taken together, this
argues that, as expected, AzTax do not act by reducing the overall
number of MTs, but rather by suppressing MT polymerisation
dynamics.
AzTax allow subcellular photocontrol of neuronal MT
dynamics. Having demonstrated MT control with spatial reso-
lution to single cells, we now wished to examine the performance
of AzTax as applied to subcellular resolution. Small molecule
inhibitors diffuse rapidly within cells, so using them to achieve
sustained subcellular patterning of biological effects is challen-
ging. Yet, for potential applications in neurobiology, the highly
polarised, elongated neuronal cell shape should restrict diffusion
and favour subcellular resolution. We used mature cultured rat
hippocampal neurons with well-developed dendrites, and trans-
fected these cells with EB3-tdTomato for imaging. For each
neuron, we selected equal-sized areas along independent pro-
cesses, and monitored their EB3 dynamics before and during
AzTax3MP treatment, with ROI-localised 405 nm application to
one area (Fig. 6 and Supplementary Movies 5–8).
Kymographs of these areas reveal localised reductions in MT
polymerisation dynamics in 405 nm-illuminated ROIs in the
presence of AzTax3MP, while no significant changes are seen in
other dendritic processes; and internal controls before/after
AzTax application confirmed that no significant photobleaching
is caused by 405 nm illumination before AzTax application
(Fig. 6a). The induction of inhibition in the ROI was typically
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Fig. 3 AzTax3MP light-dependently disrupts MTs in cultured cells. Immunofluorescence staining indicates dose- and light-dependent disruption of MT
organisation, mitotic completion, and cell viability. HeLa cells treated with AzTax3MP, docetaxel, or DMSO cosolvent only for 24 h; α-tubulin in green,
DNA in blue; docetaxel positive control at 0.1 µM; DMSO cosolvent at 1% in all conditions; scale bars 25 µm (staining was repeated twice after two
independent experiments and evaluated each time by at least two scientists independently).
a b c
Fig. 4 AzTax3MP leads to dose- and light-dependent cell-cycle arrest. a Flow cytometry analysis of cell-cycle repartition shows that AzTax3MP leads to
a light-dependent shift of living cells towards G2/M phase. b, c The cell-cycle distribution of AzTax-treated cells approaches that of docetaxel-treated cells
in a dose- and light-dependent manner. HeLa cells treated under light/dark conditions for 24 h (d indicates dark and λ indicates lit conditions; pos. indicates
docetaxel control at 0.1 µM; n= 3 biologically independent experiments, except n= 4 for 0.75 µM AzTax3MP and n= 5 for cosolvent and docetaxel
controls; data shown as mean with s.d.).
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clear within ca. 1–3 min, which is approximately one order of
magnitude slower than in the whole-cell photoswitching experi-
ments of Fig. 5, and which may partially reflect the lower AzTax
concentration that was selected to avoid complications with the
more sensitive neurons. Statistics collected over multiple cells
highlighted the reproducibility of using ROI-localised AzTax3MP
illumination to deliver subcellularly localised MT polymerisation
inhibition in this system (Fig. 6b).
Collectively, these results demonstrate the use of AzTax3MP as
a powerful tool to directly optically modulate endogenous MT
network architecture, polymerisation dynamics and MT-
dependent functions in live cells with excellent spatiotemporal
control.
Discussion
Photocontrol over protein function is an attractive method to
study anisotropic, multifunctional cellular systems, since it can
deliver the spatiotemporal specificity required to focus on specific
roles or aspects within these complex biological systems. Small
molecule photopharmaceuticals have already proven valuable
photocontrol tools because of their ability to address such targets
that are not directly accessible to optogenetics, such as the MT
cytoskeleton (for which a range of photoswitchable depolymer-
ising agents have recently been reported16,28,30). Here we have
expanded the scope of photopharmaceutical MT reagents to
demonstrate the first photoswitchable MT stabilising agents.
Through structure-photochemistry/activity-relationship studies,
we have selected a lead compound AzTax3MP that gives robust,
in situ photoswitchable MT stabilising activity in cell-free and
cellular assays, and can light-dependently reproduce key direct as
well as downstream biological effects of the taxanes but with
excellent spatiotemporal control down to the subcellular level.
While this is a promising starting point for further reagent
optimisation, we believe that AzTax3MP itself will already find a
a
b c d
Fig. 5 AzTax photoswitching allows cell-precise, temporally reversible inhibition of MT polymerisation dynamics. Data related to Supplementary
Movies 1 and 2. HeLa cells transfected with EB3-tdTomato treated with 1% DMSO cosolvent with or without 1 µM AzTax3MP. a, b Target cells (violet
arrowheads) were selectively illuminated with 405 nm in bursts, and EB3 tracking in defined regions of interest (ROIs) performed. a Target ROIs in frames
acquired immediately after 405 nm illumination are outlined in violet, target ROIs in t0 and post-recovery frames (ca. 80 s after 405 nm illumination
periods) are outlined in dotted white; nontarget cells are indicated with white arrowheads; scale bars indicate 10 µm. b Quantification of EB3 comet counts
(averages over n= 7 cells per treatment group across 3 experiments, each cell’s EB3 comet count time course was normalised to the average of the first
ten frames) in target ROI and in non-illuminated cells. Periods of ROI illumination with 405 nm are shaded in violet; times of frames from the representative
movies shown in (a) are indicated with dotted lines annotated with the times, data shown as group-average of EB3 comet count time course (normalised to
initial count) with s.e.m. For clarity, data for cosolvent-only areas are shown with LOWESS fits. c, d HeLa cells transfected with EB3-tdTomato were treated
with either 1 µM AzTax3MP or DMSO cosolvent only, and imaged directly after drug application for 2.4min with 405 nm illumination (signified by "λ") or
without (signified by “d”). Supplementary Movies were analysed for c EB3 comet velocity (n= 12 cells for AzTax3MP; n= 13 cells for cosolvent
conditions), and d EB3 comet counts, normalised to cell surface area (n= 13 cells for AzTax3MP lit and both cosolvent conditions; n= 14 cells for
AzTax3MP dark condition). EB3 comet velocity could not be meaningfully analysed in AzTax3MP-treated cells under 405 nm illumination due to the
strong loss of EB3 comets and is therefore not represented. Data are shown as mean with s.d. Unpaired, two-tailed t test: ***P= 0.001 (95% CI
0.035–0.093), ****P < 0.0001 (95% CI 0.089–0.14), ns denotes not significant, no adjustments for multiple comparisons.
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a
b
Fig. 6 Manipulation of MT polymerisation dynamics in subcellular ROIs of rat primary hippocampal neurons using AzTax3MP. Data related to
Supplementary Movies 5–8. a, b Cultured primary neurons (9 days in vitro) transfected with EB3-tdTomato treated with 1% DMSO were initially imaged
for EB3 for 10min while a ROI (violet box) was pulsed with 405 nm light, establishing baselines for EB3 activity in the cell and in the ROI, which were
demonstrated to be light-independent. The same neurons were then exposed to 0.5 µM AzTax3MP and immediately imaged for another 10 min; during
this time the same ROI (violet box) was pulsed with 405 nm light beginning at 2 min into the acquisition (indicated by dotted lines). a Cell images with
areas marked, and corresponding kymographs of these areas. The ROI pulsed with 405 nm is boxed in violet, the non-ROI areas (not pulsed with 405 nm)
are boxed in orange and green. Scale bars indicate 10 µm. b Normalised area-average pixel EB3 intensities (with s.e.m.), for areas treated with or without
AzTax3MP and 405 nm pulsing (n = 4 cells). For clarity, data for cosolvent-only areas are shown as spline fits; see Supplementary Note 4 for further
details.
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range of applications particularly in embryology, neuroscience
and studies of cell motility and polarity, where its spatiotempo-
rally specific bioactivity will enable studies not previously
possible.
Liu et al. also recently reported photoswitchable MT stabili-
sation, using a photoswitchable supramolecular host-guest system
intended to crosslink cellular MTs42. However, these effects were
also reproduced when the tubulin stabilisation motif was
deleted43, and it remains unclear if the host-guest system could
perform specific tubulin binding44. The druglike reagents devel-
oped in this work, offering robust and structurally rationalisable
performance, may therefore be valuable to address still-
unmet needs.
If AzTax reagents with still greater bioactivity differentials
could be accessed, this would improve reagent performance with
respect to several limitations of the current best candidate
AzTax3MP. This reagent’s dynamic range of bioactivity photo-
switching is between two- and six-fold, depending on the assay
readout. Thus, relatively precise concentration tuning is needed to
find the best working concentration, and background activity
before photoactivation may be observed depending on the assay
and conditions. Determining the sources of the differential
bioactivity between AzTax isomers in living cells is therefore key
for reagent optimisation. Since modifying polarity at a distal site
that should not clash sterically with the protein gave a 40-fold
change of apparent potency (AzTax3DEA compared to
AzTax3DMA), we believe that the sterics of the AzTax isomers
are not necessarily the sole determinant of cellular bioactivity.
Yet, polarity-dependent cellular biolocalisation or penetration
cannot entirely explain the photoswitchable activity of
AzTax3MP since it shows isomer-dependent activity in cell-free
assays also, so the azobenzene must significantly impact protein-
ligand affinity. Therefore, we conclude that maximising the
bioactivity difference between isomers will require photoswitches
with isomer-dependency both of sterics and of polarity. We note
too that the completeness of the E→Z photoswitchability of the
azobenzene was not correlated to the photoswitchability of bio-
logical activity (c.f. AzTax3MTM, AzTax4MP). Since the Z-
AzTax were typically the more-active isomers, we conclude that
further defavouring the binding of the E-isomer while allowing
the Z-isomer to retain bioactivity, e.g. by tuning sterics and
polarity, is likely the best way to maximise the photocontrol over
inhibition. Research in these directions is underway.
Reducing the halflife of spontaneous relaxation of an AzTax to
its less-binding isomer, could also offer perspectives for
improving the ease of cellularly or subcellularly specific photo-
control. Faster relaxation could reduce the biological effects of a
photoactivated isomer diffusing away from a desired spatial and
temporal locality, and so improve spatiotemporal precision.
However, if relaxation becomes too fast, the requirements for
repeated localised illuminations may become the limiting factor
for compound utility. We estimate that relaxation on the scale of
seconds, or hundreds of microseconds, would best address most
desirable short-term assays. While the relaxation speed of
AzTax3MP was in this respect too slow, and that of
AzTax3DMA was too fast, it is likely that by electronic tuning
of the azobenzene’s distal phenyl ring, more useful derivatives
with intermediate relaxation rates can be obtained. Research in
this direction is ongoing.
Photopharmacology studies often assume that increasing the
dynamic range of isomeric photoswitchability under a freely
available choice of illumination conditions, and red-shifting
overall absorption wavelengths, are required for improved bio-
logical performance. However, in the case of the current or any
potentially tuned future AzTax stabilisers, as elsewhere, probably
neither is true:
First, after Z-AzTax induces increased MT rescues, which alter
MT dynamics and network architecture, the downstream MT-
dependent biology probably cannot be rapidly returned to its
usual state even if the stabiliser would be totally removed (e.g., by
complete back-isomerisation to a hypothetically non-binding
state). This is because any AzTax-stabilised MTs are likely to be
organised abnormally, and will presumably require time to break
down and return tubulin monomer to the cytoplasmic pool so
that a functional, directional MT network can be rebuilt. There-
fore, there is probably a limit to the temporal resolution of true
biological reversibility that any photoswitchable stabiliser can
display, even if selected readouts (such as speed of polymerisation
of individual MTs) recover more quickly. With this consideration
in mind, we do not believe that improving the completeness of
bidirectional isomeric photoswitchability45 will be as important
for AzTax development as for other classes of inhibitors that can
feature instantaneous downstream biological response.
Second, red-shifting photoswitch absorption wavelengths is
also likely to be counterproductive for microscopy, since there are
few fluorescent proteins with significant excitation efficiency at
laser lines above 561 nm (typically the next wavelength available
is 647 nm). Therefore, maintaining orthogonality to the widest
possible range of imaging wavelengths by blue-shifting is in our
opinion and experience more advantageous, since it can keep
other imaging channels vacant for multiparameter, photo-
orthogonal studies28. However, a key property that should be
readily tunable to the advantage of this system is the E→Z pho-
toisomerisation efficiency at 405 nm, which is usually the only
microscopy laser available in the 350–440 nm range. Here we
consider that improved performance for AzTax-like reagents will
depend on optimising photoconversion at the wavelength/s that
will in practice be used for their photocontrol. Developing a set of
standard photoswitches with better 405 nm E→Z photoconversion
than these para-alkoxyazobenzenes (~46% Z) yet with similar
polarity and substantial stability against thermal relaxation, is a
nontrivial goal of our ongoing research.
From a biological perspective, while AzTax have reproduced
the effects expected for taxanes across these studies, comparing
their mechanism more deeply remains to be addressed. Given the
structural overlap of the binding pharmacophores (Fig. 1; ca. 215
Å2 of paclitaxel’s total polar surface area (221 Å2) overlaps with
that of AzTax3MP (249 Å2)) we consider it likely that their
effects will prove similar in a variety of settings. This would open
up possibilities towards e.g., time-resolved studies of the effects of
taxane binding relying on these photoswitchable analogues.
The AzTax photoswitchable MT stabilisers can be used in
conjunction with long term, in situ photoswitching in live cells to
control critical biology from cytoskeleton architecture to cell
survival. In short-term experiments, they can reliably apply cell-
specific and temporally reversible MT inhibition under straight-
forward optical control, and have allowed subcellularly resolved
inhibition in primary cells with unusual geometry. By com-
plementing the existing MT-depolymerising photo-
pharmaceuticals, the development of AzTax now brings both
principal modes of pharmacological MT modulation under
optical control.
AzTax reagents open up a multitude of possibilities for high-
precision biological studies not possible with previous methods.
They may contribute to studies across a variety of settings where
temporally, cell- or subcellularly specific roles of MTs either are
unclear, or else determine downstream biology that is itself of
interest. For example, cell specific, temporally precise modulation
of MT stability and dynamics may be particularly useful for
studies of rapid coordinated processes such as mitotic progres-
sion, transport, migration and immune cell response, even in
complex environments. AzTax may also find particular utility in
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neurobiology, for example in exploring the recently discovered
important roles of MTs in developing and regenerating neurons.
Although MT stabilisation during development was shown to
determine axonal identity and remodelling, MT stabilisation in
mature neurons seems to promote axonal regeneration by redu-
cing the formation of retraction bulbs and modulating glial scar
formation after spinal cord injury14,32,46–48. However, the tem-
poral characteristics of these phenomena are unclear, and the
roles of MT stabilisation in surrounding glia and immune cells
rather than in damaged neurons themselves have not yet been
resolved. Photopharmaceutical stabilisers could shed new light on
this field by stimulating the phenomena with high enough spa-
tiotemporal resolution to clarify the primary processes
responsible32,33.
In the field of pharmacology, it is still to a large degree
unclear38 how the blockbuster taxane drugs exert their cellular/
tissue-level effects in vivo. This provides enormous clinically
driven interest in increasing the understanding of taxane phar-
macology: both towards improved paclitaxel-site antimitotic
therapeutics, and towards designing better combination treat-
ment regimens involving these broad-spectrum cancer che-
motherapeutics. Against this backdrop too, AzTax offer an
intriguing method for precise studies, that may clarify the spa-
tiotemporal dependency of biological action of the parent taxanes.
Beyond the first generation of AzTax reagents, we have also
identified perspectives for further improving AzTax’s photo-
control of biological function through structure-photochemistry/
activity-relationship studies. This opens up several avenues for
applying fundamental research in the rapidly evolving field of
chemical photoswitches to generate specialty MT stabiliser pho-
topharmaceuticals for cell-free mechanistic studies, cell biology,
and towards in vivo use. More broadly, this work will also guide
and encourage further photopharmaceutical reagent development
for other proteins inaccessible to direct optogenetics, including
the actin cytoskeleton.
In conclusion, we believe that the AzTax will prove useful in
studies from intracellular transport, cell division and cell motility,
to neurobiology; and that this first demonstration of photo-
switchable MT stabilisers is a substantial step towards high-
spatiotemporal-precision studies of a range of critical processes in
cell biology.
Methods
Full and detailed experimental protocols can be found in the Supplementary
Information.
Compound synthesis and characterisation. Reactions and characterisations were
performed by default with non-degassed solvents and reagents (Sigma-Aldrich,
TCI Europe, Fisher Scientific), used as obtained, under closed air atmosphere
without special precautions. Manual flash column chromatography was performed
on Merck silica gel Si-60 (40–63 μm). MPLC flash column chromatography was
performed on a Biotage Isolera Spektra, using Biotage prepacked silica cartridges.
Thin-layer chromatography was run on 0.25 mm Merck silica gel plates (60, F-
254), with UV light (254 and 365 nm) for visualisation. NMR characterisation was
performed on Bruker 400 or 500MHz spectrometers. HRMS was performed by
electron impact at 70 eV with Thermo Finnigan MAT 95 or Jeol GCmate II
spectrometers; or by electrospray ionisation with a Thermo Finnigan LTQ FT Ultra
Fourier Transform Ion Cyclotron resonance spectrometer. Analytical HPLC-MS
was performed on an Agilent 1100 SL HPLC with H2O:MeCN eluent gradients, a
Thermo Scientific Hypersil GOLD™ C18 column (1.9 μm; 3 × 50mm) maintained
at 25 °C, detected on an Agilent 1100 series diode array detector (DAD) and a
Bruker Daltonics HCT-Ultra mass spectrometer.
Photocharacterisation. UV–Vis-based studies (determination of absorption
spectra, photostationary states, reversibility of photoisomerisation, and Z to E
relaxation) were performed on a Varian CaryScan 60 (1 cm pathlength) at room
temperature with model photoswitches that were water-soluble analogues of the
AzTax species, since reliable UV–Vis studies require compound concentrations
around 25–50 µM, while the AzTax compounds are only reliably molecularly
soluble at such concentrations with high cosolvent percentages (e.g., 50%
DMSO) that do not reflect the intracellular environment and also alter the
isomers’ spectra, quantum yields, and relaxation times. We synthesised and used
di(2-ethanol)amine carboxamides as water-soluble analogues of the taxane
carboxamide AzTax (see Supplementary Information) enabling measurements
in PBS at pH ~7.4 with only 1% of DMSO as cosolvent, thus matching the
intracellular environment around the AzTax’ protein target, tubulin. Star model
3W LEDs (360–530 nm, each FWHM ~25 nm, Roithner Lasertechnik) were used
for photoisomerisations in cuvette that were thus predictive of what would be
obtained in the cytosol during LED-illuminated cell culture. Spectra of pure E-
and Z-isomers were acquired from the HPLC’s inline Agilent 1100 series DAD
over the range 200–550 nm, manually baselining across each elution peak of
interest to correct for eluent composition.
Tubulin polymerisation in vitro. In total, 99% purity tubulin from porcine brain
was obtained from Cytoskeleton Inc. (cat. #T240) and polymerisation assays run
according to manufacturer’s instructions. Tubulin was incubated at 37 °C with lit-
or dark-AzTax (10 µM) in buffer (with 3% DMSO, 10% glycerol) and GTP (1 mM),
and the change in absorbance at 340 nm was monitored over 15 min at 37 °C49.
Standard cell culture. HeLa (ATCC CCL-2) and COS-7 (ATCC CRL-1651) cells
were maintained under standard cell culture conditions in Dulbecco’s modified
Eagle’s medium supplemented with 10% foetal calf serum (FCS), 100 U mL−1
penicillin and 100 µg mL−1 streptomycin, at 37 °C in a 5% CO2 atmosphere (see
also Supplementary Information for protocols for other cell types). For long-term
assays under photoswitching, HeLa cells were transferred to phenol red free
medium prior to assays. Compounds (in the all-E state) and cosolvent (DMSO; 1%
final concentration) were added via a D300e digital dispenser (Tecan). Treated cells
were then incubated under dark (light excluded) or lit conditions (where 75 ms
illumination pulses were applied to microtiter plates every 15 s by self-built
wavelength-specific multi-LED arrays, to create and maintain the wavelength-
dependent photostationary state isomer ratios throughout the experiment16).
Antiproliferation assay. As a proxy readout for viable cells, mitochondrial dia-
phorase activity in HeLa cell line was quantified by measuring the reduction of
resazurin (7-hydroxy-3H-phenoxazin-3-one 10-oxide) to resorufin. 5000 cells per
well were seeded on 96-well plates. After 24 h, cells were treated with E-AzTax,
shielded from ambient light with light-proof boxes, and exposed to the appropriate
light regimes. Following 48 h of treatment, cells were incubated with 20 µL of 0.15
mgmL−1 resazurin per well for 3 h at 37 °C. The resorufin fluorescence (excitation
544 nm, emission 590 nm) was measured using a FLUOstar Omega microplate
reader (BMG Labtech). Results are represented as percent of DMSO-treated control
(reading zero was assumed to correspond to zero viable cells) and represented as
mean of at least three independent experiments with s.d.
Cell-cycle analysis. E-AzTax were added to HeLa cells in 6-well plates (seeding
density: 300,000 cells per well) and incubated under dark or lit conditions for 24 h.
Cells were harvested and fixed in ice-cold 70% ethanol then stained with propi-
dium iodide (PI, 200 µg mL−1 in 0.1% Triton X-100 containing 200 µg mL−1
DNase-free RNase (Thermo Fischer Scientific EN0531) for 30 min at 37 °C. Fol-
lowing PI staining, cells were analysed by flow cytometry using an LSR Fortessa
(Becton Dickinson) run by BD FACSDiva 8.0.1 software. The cell-cycle analysis
was subsequently performed using FlowJo-V10 software (Tree Star Inc.). Cells were
sorted into sub-G1, G1, S and G2/M phase according to DNA content (PI signal).
Quantification from gating on the respective histograms is shown as percent of live/
singlet/PI-positive parent population per cell-cycle phase across different con-
centrations of the compound. Every experiment was performed in technical tri-
plicates, at least three times independently, with a minimum of 10,000 (mean:
14,000) PI-positive singlet cells analysed per replicate.
Immunofluorescence staining. HeLa cells seeded on glass coverslips in 24-well
plates (50,000 cells per well) were left to adhere for 24 h then treated for 24 h with
AzTax under dark or lit conditions. Cover slips were washed then fixed with 0.5%
glutaraldehyde, quenched with 0.1% NaBH4, blocked with PBS+ 10% FCS, treated
with rabbit alpha-tubulin primary antibody (ab18251, abcam), washed, and incu-
bated with donkey-anti-rabbit Alexa fluor 488 secondary antibody (A-21206,
Invitrogen). After washing with PBS, coverslips were mounted onto glass slides
using Roti-Mount FluorCare DAPI (Roth) and imaged with a Leica SP8 confocal
microscope with a 63 × glycerol objective (DAPI: 405 nm, tubulin: 488 nm). Z-
stacks (step size: 0.33 µm) were projected using Fiji and gamma values adjusted for
visualisation.
EB3 imaging with cell-specific photoisomerisation. HeLa cells were transiently
transfected with EB3-tdTomato (gift from Erik Dent; Addgene #50708) using
FuGENE 6 (Promega) according to manufacturer’s instructions (see Supplemen-
tary Information for all other imaging protocols). Cells were imaged on a Nikon
Eclipse Ti microscope equipped with a perfect focus system (Nikon), a spinning
disk-based confocal scanner unit (CSU-X1-A1, Yokogawa) and an Evolve 512
EMCCD camera (Photometrics) with a stage top incubator INUBG2E-ZILCS
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(Tokai Hit) and lens heating calibrated for incubation at 37 °C with 5% CO2. Cells
were incubated in standard cell culture medium with 0.5% DMSO cosolvent, with
or without E-AzTax3MP, for 10 min before microscope image acquisition using
MetaMorph 7.7 was begun, with EB3-tdTomato imaging performed at 561 nm
(0.17 mW, 300 ms every 4 s). Periods of intracellular-ROI-localised 405 nm illu-
minations (10 µW, 1 scan every 4 s during 24 s periods) were applied during
imaging. Acquisition used a Plan Apo VC 60 × NA 1.4 oil objective. Comet count
analysis was performed in ImageJ using the ComDet plugin (E. Katrukha, Uni-
versity of Utrecht, https://github.com/ekatrukha/ComDet).
Subcellular MT manipulation in primary hippocampal neurons. Mouse primary
hippocampal neurons were derived from hippocampi of embryonic day 18 pups
and plated on poly-L-lysine (Sigma-Aldrich) and laminin (Roche) coated cover-
slips. Primary neurons were cultured in Neurobasal medium (NB) supplemented
with 2% B27 (Gibco), 0.5 mM glutamine (Gibco), 15.6 µM glutamate (Sigma-
Aldrich) and 1% penicillin/streptomycin (Gibco) at 37 °C and 5% CO2. Neurons
were transfected with EB3-tdTomato on the 7th day in vitro (DIV 7) using
Lipofectamine 2000 (Invitrogen) and were imaged at DIV 9. Neurons were imaged
on the same system used for cell-specific-photoisomerisation experiments
(described above). Neurons were first immersed in conditioned NB with 1%
DMSO. EB3-tdTomato was imaged at 561 nm (0.1 mW, 400 ms every 4 s), while a
ROI (violet box) was pulsed with 405 nm light (0.2 mW, 8 ms per trace) tracing
over the ROI four times every 4 s with imaging frames interleaved. The same
neurons were then immersed in conditioned NB with 1% DMSO and 0.5 µM
AzTax3MP and immediately imaged for another 10 min; during this time the same
ROI (violet box) was pulsed with 405 nm light (same protocol) starting 2 min into
the acquisition.
Statistics. If not indicated otherwise all statistical analyses are unpaired, two-tailed
Student’s t test conducted with GraphPad Prism for Mac 8.4. P values below 0.05
were considered significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in this published article and
its Supplementary Information files, including the Source Data file provided (raw data for
Figs. 2–5 and Supplementary Figs. 1–5). This and all data of the study can also be
obtained from the authors upon request. None of these datasets are resources of public
interest and therefore are not archived publicly in other forms. All materials are available
from the Corresponding Author upon request. Source data are provided with this paper.
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